WO2014139410A1 - Method for preparing intermediate of azelnidipine - Google Patents
Method for preparing intermediate of azelnidipine Download PDFInfo
- Publication number
- WO2014139410A1 WO2014139410A1 PCT/CN2014/073222 CN2014073222W WO2014139410A1 WO 2014139410 A1 WO2014139410 A1 WO 2014139410A1 CN 2014073222 W CN2014073222 W CN 2014073222W WO 2014139410 A1 WO2014139410 A1 WO 2014139410A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reaction
- diphenylmethyl
- add
- acid
- dichloromethane
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- ZKFQEACEUNWPMT-UHFFFAOYSA-N Azelnidipine Chemical compound CC(C)OC(=O)C1=C(C)NC(N)=C(C(=O)OC2CN(C2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZKFQEACEUNWPMT-UHFFFAOYSA-N 0.000 title abstract description 4
- 229950004646 azelnidipine Drugs 0.000 title abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 17
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 238000005886 esterification reaction Methods 0.000 claims abstract description 11
- 238000003482 Pinner synthesis reaction Methods 0.000 claims abstract description 8
- MMAJXKGUZYDTHV-UHFFFAOYSA-N 1-benzhydrylazetidin-3-ol Chemical compound C1C(O)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 MMAJXKGUZYDTHV-UHFFFAOYSA-N 0.000 claims abstract 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 63
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 39
- -1 3-amino-3-iminopropionic acid-1-(diphenylmethyl)-3-azetidinyl acetate Chemical compound 0.000 claims description 30
- 238000002360 preparation method Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 150000007530 organic bases Chemical class 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 7
- 239000005695 Ammonium acetate Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 229940043376 ammonium acetate Drugs 0.000 claims description 7
- 235000019257 ammonium acetate Nutrition 0.000 claims description 7
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 7
- 239000007789 gas Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 4
- 150000007529 inorganic bases Chemical class 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 238000005273 aeration Methods 0.000 claims description 2
- VBZCVIBBTVSYSO-UHFFFAOYSA-N ethyl propanimidate Chemical compound CCOC(=N)CC VBZCVIBBTVSYSO-UHFFFAOYSA-N 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940011051 isopropyl acetate Drugs 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 4
- 239000012065 filter cake Substances 0.000 claims 3
- MLIREBYILWEBDM-UHFFFAOYSA-M 2-cyanoacetate Chemical compound [O-]C(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-M 0.000 claims 2
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 claims 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000012044 organic layer Substances 0.000 claims 2
- 239000011345 viscous material Substances 0.000 claims 2
- KSZGPBFUBSHVTO-UHFFFAOYSA-N (1-benzhydrylazetidin-3-yl) 2-cyanoacetate Chemical compound C1C(OC(CC#N)=O)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 KSZGPBFUBSHVTO-UHFFFAOYSA-N 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- JKRHDMPWBFBQDZ-UHFFFAOYSA-N n'-hexylmethanediimine Chemical compound CCCCCCN=C=N JKRHDMPWBFBQDZ-UHFFFAOYSA-N 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- 230000032050 esterification Effects 0.000 abstract description 6
- DCGRISOXIFQLPD-UHFFFAOYSA-N acetic acid;(1-benzhydrylazetidin-3-yl) 3-amino-3-iminopropanoate Chemical compound CC(O)=O.C1C(OC(=O)CC(=N)N)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 DCGRISOXIFQLPD-UHFFFAOYSA-N 0.000 abstract 2
- 239000002994 raw material Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 9
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- MROCJMGDEKINLD-UHFFFAOYSA-N dichlorosilane Chemical compound Cl[SiH2]Cl MROCJMGDEKINLD-UHFFFAOYSA-N 0.000 description 3
- 229940127292 dihydropyridine calcium channel blocker Drugs 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 239000002866 dihydropyridine calcium channel blocker Substances 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- IXADHCVQNVXURI-UHFFFAOYSA-N 1,1-dichlorodecane Chemical compound CCCCCCCCCC(Cl)Cl IXADHCVQNVXURI-UHFFFAOYSA-N 0.000 description 1
- YBQZXXMEJHZYMB-UHFFFAOYSA-N 1,2-diphenylhydrazine Chemical compound C=1C=CC=CC=1NNC1=CC=CC=C1 YBQZXXMEJHZYMB-UHFFFAOYSA-N 0.000 description 1
- QHJJSLUZWHFHTK-UHFFFAOYSA-N 3-amino-3-azaniumylidenepropanoate Chemical compound NC(=N)CC(O)=O QHJJSLUZWHFHTK-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- LYCCGKRACIPNEM-UHFFFAOYSA-N SN(C1=CC=CC=C1)S.NN Chemical compound SN(C1=CC=CC=C1)S.NN LYCCGKRACIPNEM-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- GDJYIXGPYCKDOV-UHFFFAOYSA-N n-phenylthiohydroxylamine Chemical compound SNC1=CC=CC=C1 GDJYIXGPYCKDOV-UHFFFAOYSA-N 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Definitions
- the invention belongs to the technical field of medicine and provides an important intermediate of dihydropyridine calcium antagonist adipine, 3-amino-3-iminopropionic acid-1-(diphenylhydrazinyl)-3-azetidine The synthesis process of ester acetate. Background technique
- Azelnidipine is a new type of dihydropyridine calcium channel blocker developed by Sankyo and Ube Industries of Japan. It was approved for sale in Japan in late May 2003 under the trade name Calblock. Adipine has a selective blockade of calcium channels in arterial smooth muscle cells, it can dilate blood vessels, reduce peripheral vascular resistance and arterial pressure, and is widely used clinically for mild or moderate essential hypertension, renal disorders with hypertension And treatment of severe hypertension. Compared with nicardipine and nifedipine dihydropyridine calcium channel blockers, adipine is superior in selectivity, long-lasting and long-lasting, and has little effect on the heart.
- references to the preparation of agdipine include: European patents EP0266922; Chinese patent CN201010516967.7; Chinese Journal of Medicinal Chemistry, 2010, 20 (3): 192-194; Chinese Journal of Pharmaceutical Industry, 2008, 39 (3): 163-165; Chemical Industry and Engineering, 2009, 26 ( 1 ): 15-18; Qilu Pharmacy, 2005, 24 (6): 365-366.
- the preparation method of adipine in these literatures is based on the reaction of epichlorohydrin and diphenylamine with N-alkylation, cyclization, esterification, Pinner synthesis, neutralization, and oxime reaction.
- 3-amino-3-iminopropionic acid-1- (3) is prepared by a three-step reaction from cyanoacetate-1-diphenylhydrazin-3-azetidinyl ester (3) according to the method specifically reported in the above literature.
- Diphenylhydrazino)-3-azetidinyl acetate (6) the reaction operation is cumbersome, and it is easy to produce by-products of hydrolysis of ester bonds and hydrolysis of imid bonds (7) and (8), three-step reaction.
- the total yield is only 20 ⁇ 30%, and the purification of the product is difficult, which seriously affects the quality of the final product and greatly increases the production cost.
- the adipine intermediate of the present invention 3-amino-3-iminopropionic acid-1-(diphenylhydrazinyl)-3-azetidinyl acetate acetate has the following structural formula:
- the preparation method of 3-amino-3-iminopropionic acid-1-(diphenylindenyl)-3-azetidinyl acetate of the present invention comprises the following steps: 1) Esterification: 1-diphenylhydrazin-3-azetidinol (2), cyanoacetic acid (1) and N,N-dicyclohexylcarbodiimide (DCC) in organic solvent at 0 ⁇ Reacting at 80 ° C, to obtain 7-diphenylindolyl-3-azetidinyl cyanoacetate (3);
- the carbodiimide (DCC) is reacted in an organic solvent at 0 to 80 ° C for 0.5-11 hours. After cooling, suction filtration, the filtrate is washed with alkali, washed with water, dried and evaporated to dryness to give cyanoacetate-1-diphenylhydrazino-3-azetidinyl ester (3).
- organic solvent is selected from the group consisting of acetone, dichlorodecane, diethyl ether, chloroform, ethyl acetate, and acetic acid
- organic solvents are good solvents for 1,3-dicyclohexylurea (DCU) and a good solvent for the product cyanoacetate-1-diphenylindol-3-azetidine, which is at 0°.
- DCU 1,3-dicyclohexylurea
- the solubility of the solute at C is greater than 30 g/100 mL, and the poor solvent is such that the solubility of the solute is less than lg/100 mL at 0 °C.
- a preferred organic solvent is one selected from the group consisting of dichlorosilane, chloroform, diethyl ether, ethyl acetate, toluene, acetonitrile or a mixed solvent of one or more.
- the alkaline water is a saturated sodium bicarbonate solution.
- the base is selected from one of an organic base and an inorganic base.
- the organic base is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl
- RR 2 and R 3 are independently selected from the group consisting of hydrogen, dC 4 alkyl, phenyl, phenyl dC 4 alkyl, with the proviso that R 1 R 2 and R 3 are not hydrogen at the same time.
- Preferred organic bases are selected from the group consisting of decylamine, ethylamine, propylamine, decylamine, diethylamine, decylamine, triethylamine, aniline, N-mercaptoaniline, diisopropylethylamine, hydrazine, hydrazine-di Mercaptoaniline, ethylenediamine.
- More preferred organic bases are selected from the group consisting of diamine, diethylamine, triethylamine, aniline, ethylenediamine. It refers to an organic base C r C 4 primary amines, aromatic primary amines, symmetric or asymmetric C r C 4 secondary amine, symmetrical or asymmetrical aromatic primary amine, symmetrical or asymmetrical tertiary C r C 4, symmetric or asymmetric Aromatic tertiary amine, aliphatic diamine.
- the inorganic base is selected from the group consisting of sodium carbonate, potassium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate, sodium hydroxide and potassium hydroxide.
- the base is added so that the pH of the solution is from 7 to 10, preferably from 7 to 8.
- the present invention uses an organic base in the neutralization reaction, which reduces side reactions and improves product purity and yield.
- Preparation of an important intermediate of adipinepine using the method of the invention 3-amino-3-iminopropionic acid -1- (diphenylhydrazine)
- Method 1 Add 1-diphenylhydrazin-3-azetidinol (2, 235 g, 0.983 mol) and cyanoacetic acid (1, 100 g, 1.18 mol) to 1.5 mL of dichloromethane, and stir until fully dissolved.
- ⁇ ⁇ -dicyclohexylcarbodiimide (DCC, 243 g, 1.18 mol) was added at 0-10 ° C and allowed to react at room temperature for 3 h. After the completion of the reaction, the reaction mixture was cooled to 0 to 5 ° C, and filtered, filtered, washed with a small portion of dichloromethane. The organic solvent was evaporated to dryness under reduced pressure and dried to give 275 g of white solid.
- DCC ⁇ -dicyclohexylcarbodiimide
- Method 2 chloroform was used as the reaction solvent, and the operation was the same as above, and the reaction was carried out at 55 ° C for 5 hours, the HPLC purity was 98.7%, and the product yield was 95.3%.
- Method 1 Add 1.4 L of dichloromethane to Intermediate 4, cool to 0-5 ° C, add dry diethylamine (182 mL, 1.76 mol) to the solution, adjust pH 7-8, continue to stir after the dropwise addition. 2h. The mixture was suction filtered, and the filtrate was evaporated to dryness vacuo.
- Method 5 Add 1.4 L of dichloromethane to Intermediate 4, cool to 0-5 ° C, add potassium carbonate (242.88 g, 1.76 mol) to the solution in portions, adjust pH 7-8, continue stirring for 2 h. . The mixture was suction filtered, and the filtrate was evaporated to dryness vacuo.
- Method 6 Neutralize with sodium carbonate, and operate as above.
- Method 7 Neutralize with sodium hydroxide, and operate as above.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Disclosed is a method for preparing 3-amino-3-iminopropanoic acid-1-(diphenylmethyl)-3-azetidinyl ester acetate used as intermediate of azelnidipine. In such method, 1-diphenylmethyl-3-azetidin-ol and cyano acetic acid used as raw materials, is subjected to the four steps of esterification, Pinner reaction, neutralization, and amidination to generate 3-amino-3-iminopropanoic acid-1-(diphenylmethyl)-3-azetidinyl ester acetate. By selecting suitable solvents and reaction conditions, the method has the advantages of mild reaction conditions, simple post-treatment and high reaction yield.
Description
一种阿折地平中间体的制备方法 技术领域 Preparation method of adipinepine intermediate
本发明属于医药技术领域,提供了一种二氢吡啶类钙拮抗剂阿折 地平重要中间体 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙 酸盐的合成工艺。 背景技术 The invention belongs to the technical field of medicine and provides an important intermediate of dihydropyridine calcium antagonist adipine, 3-amino-3-iminopropionic acid-1-(diphenylhydrazinyl)-3-azetidine The synthesis process of ester acetate. Background technique
阿折地平 (azelnidipine)是由日本 Sankyo和 Ube Industries公司共 同研制开发的一种新型的二氢吡啶类钙通道阻滞剂, 2003年 5月下 旬获准在日本上市, 商品名为 Calblock。 阿折地平对动脉平滑肌细胞 钙通道具有选择性阻滞作用, 它能扩张血管、 降低外周血管阻力和动 脉压, 临床上广泛用于轻度或中度原发性高血压、 肾障碍伴高血压以 及重症高血压等的治疗。 阿折地平与尼卡地平、硝苯地平等二氢吡啶 类钙通道阻滞剂相比, 具有选择性高、 降压作用强而持久、 对心脏影 响小等优点。 Azelnidipine is a new type of dihydropyridine calcium channel blocker developed by Sankyo and Ube Industries of Japan. It was approved for sale in Japan in late May 2003 under the trade name Calblock. Adipine has a selective blockade of calcium channels in arterial smooth muscle cells, it can dilate blood vessels, reduce peripheral vascular resistance and arterial pressure, and is widely used clinically for mild or moderate essential hypertension, renal disorders with hypertension And treatment of severe hypertension. Compared with nicardipine and nifedipine dihydropyridine calcium channel blockers, adipine is superior in selectivity, long-lasting and long-lasting, and has little effect on the heart.
目前, 有关阿折地平制备方法的参考文献包括: 欧洲专利
EP0266922; 中国专利 CN201010516967.7; 中国药物化学杂志, 2010 , 20 ( 3 ): 192-194; 中国医药工业杂志, 2008, 39 ( 3 ): 163-165; 化 学工业与工程, 2009 , 26 ( 1 ): 15-18; 齐鲁药事, 2005 , 24 ( 6 ): 365-366。 这些文献中提供的阿折地平的制备方法, 为以环氧氯丙烷 与二苯曱胺为起始原料, 经 N -烷基化、 环合、 酯化、 Pinner合成、 中和、 成脒反应先制备得到中间体 3-氨基 -3-亚氨基丙酸 -1- (二苯曱 基) -3-氮杂环丁酯乙酸盐,然后与 2-(3-硝基亚苄基)乙酰乙酸异丙酯经 Hantzsch缩合制得阿折地平。 At present, references to the preparation of agdipine include: European patents EP0266922; Chinese patent CN201010516967.7; Chinese Journal of Medicinal Chemistry, 2010, 20 (3): 192-194; Chinese Journal of Pharmaceutical Industry, 2008, 39 (3): 163-165; Chemical Industry and Engineering, 2009, 26 ( 1 ): 15-18; Qilu Pharmacy, 2005, 24 (6): 365-366. The preparation method of adipine in these literatures is based on the reaction of epichlorohydrin and diphenylamine with N-alkylation, cyclization, esterification, Pinner synthesis, neutralization, and oxime reaction. The intermediate 3-amino-3-iminopropionic acid-1-(diphenylfluorenyl)-3-azetidinyl acetate is prepared first, followed by 2-(3-nitrobenzylidene)acetyl Acepinedipine was obtained by the Hantzsch condensation of isopropyl acetate.
在该路线中酯化、 Pinner合成和中和三步反应中反应溶剂和反应 条件的控制是至关重要的。使用这些文献提供的制备方法, 我们发现 其操作繁瑣, 且收率和纯度均不理想。 The control of the solvent and reaction conditions in the esterification, Pinner synthesis and neutralization three-step reaction in this route is critical. Using the preparation methods provided by these documents, we found that the operation was cumbersome and the yield and purity were not satisfactory.
在酯化反应中, 按照上述文献具体报道的方法, 所得产品最高收 率仅为 85%, 并且纯度较差, 不易纯化, 难以得到固体产物。 In the esterification reaction, according to the method specifically reported in the above literature, the highest yield of the obtained product is only 85%, and the purity is poor, it is difficult to purify, and it is difficult to obtain a solid product.
我们发现按照上述文献具体报道的方法, 由氰乙酸 -1-二苯曱基 -3-氮杂环丁酯(3 ) 经三步反应制备 3-氨基 -3-亚氨基丙酸 -1- (二苯曱 基) -3-氮杂环丁酯乙酸盐 (6 ), 反应操作繁瑣, 且极易产生酯键水解 和亚氨键水解的副产物( 7 )和( 8 ),三步反应的总收率仅为 20~30%, 产物纯化较难, 严重影响终产品的质量, 使生产成本大大提高。
副产物 (7 )和(8 )结构式
发明内容 We have found that 3-amino-3-iminopropionic acid-1- (3) is prepared by a three-step reaction from cyanoacetate-1-diphenylhydrazin-3-azetidinyl ester (3) according to the method specifically reported in the above literature. Diphenylhydrazino)-3-azetidinyl acetate (6), the reaction operation is cumbersome, and it is easy to produce by-products of hydrolysis of ester bonds and hydrolysis of imid bonds (7) and (8), three-step reaction. The total yield is only 20~30%, and the purification of the product is difficult, which seriously affects the quality of the final product and greatly increases the production cost. Byproducts (7) and (8) structural formula Summary of the invention
本发明的目的是提供一种制备阿折地平关键中间体 3-氨基 -3-亚 氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙酸盐的方法。本发明所述阿折 地平中间体 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙酸盐 结构式如下: SUMMARY OF THE INVENTION It is an object of the present invention to provide a process for the preparation of the key intermediate of adipine, 3-amino-3-iminopropionic acid-1-(diphenylhydrazinyl)-3-azetidinyl acetate. The adipine intermediate of the present invention 3-amino-3-iminopropionic acid-1-(diphenylhydrazinyl)-3-azetidinyl acetate acetate has the following structural formula:
本发明的 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙酸 盐的制备方法, 包括以下步骤:
1 ) 酯化反应: 1-二苯曱基 -3-吖丁啶醇 (2)、 氰乙酸(1 ) 和 N,N- 二环己基碳二亚胺(DCC)在有机溶剂中于 0~80°C反应, 得氰乙酸 —7—二苯曱基 -3-氮杂环丁酯 (3); The preparation method of 3-amino-3-iminopropionic acid-1-(diphenylindenyl)-3-azetidinyl acetate of the present invention comprises the following steps: 1) Esterification: 1-diphenylhydrazin-3-azetidinol (2), cyanoacetic acid (1) and N,N-dicyclohexylcarbodiimide (DCC) in organic solvent at 0~ Reacting at 80 ° C, to obtain 7-diphenylindolyl-3-azetidinyl cyanoacetate (3);
2) Pinner反应: 将中间体(3)、 无水乙醇加入到二氯曱烷中, 搅 拌并冷却 2) Pinner reaction: Add intermediate (3), absolute ethanol to dichlorosilane, stir and cool
至 -20~25°C, 通入干燥的氯化氢气体, 然后反应液在 -20~25°C继续密 封搅拌, 得 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸 盐 (4); To -20~25 °C, dry hydrogen chloride gas is passed, and then the reaction solution is kept sealed at -20~25 °C to obtain 3-imino-3-ethoxypropionic acid-1-(diphenylfluorenyl) -3-azetidinyl ester hydrochloride (4);
3) 中和反应: 将中间体(4)溶于二氯曱烷中, 控制 -5~25°C加入 碱, 得 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯(5); 3) Neutralization reaction: The intermediate (4) is dissolved in dichloromethane, and the base is added at -5 to 25 ° C to obtain 3-imino-3-ethoxypropionic acid-1-(diphenylhydrazine). Benzyl-3-azetidinyl ester (5);
4) 成脒反应: 中间体 (5 ) 用乙腈溶解后加入醋酸铵, 升温至 40~60°C反应, 得 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙 酸盐化合物 (6)。 具体实施方式 4) Formation reaction: The intermediate (5) is dissolved in acetonitrile, ammonium acetate is added, and the temperature is raised to 40 to 60 ° C to obtain 3-amino-3-iminopropionic acid-1-(diphenylfluorenyl)-3. - azetidinium acetate compound (6). detailed description
在上述内容的基础上, 按照本领域的普通技术知识和惯用手段, 在不脱离本发明上述基本技术思想前提下 ,还可以作出多种形式的修 改、 替换或变更。 On the basis of the above-mentioned contents, various modifications, alterations or changes can be made without departing from the basic technical scope of the invention.
作为本发明优选的制备方法, 包括以下步骤: As a preferred preparation method of the present invention, the following steps are included:
1 ) 酯化反应: 1-二苯曱基 -3-吖丁啶醇 (2)、 氰乙酸(1 ) 和 N,N-二环己 1) Esterification: 1-diphenylhydrazin-3-azetidinol (2), cyanoacetic acid (1) and N,N-dicyclohexane
基碳二亚胺(DCC)在有机溶剂中于 0~80°C反应 0.5-11 小时, 反应
完毕冷却, 抽滤, 滤液碱水洗、 水洗, 干燥后蒸干溶剂, 得氰乙酸 -1- 二苯曱基 -3-氮杂环丁酯(3 ), The carbodiimide (DCC) is reacted in an organic solvent at 0 to 80 ° C for 0.5-11 hours. After cooling, suction filtration, the filtrate is washed with alkali, washed with water, dried and evaporated to dryness to give cyanoacetate-1-diphenylhydrazino-3-azetidinyl ester (3).
其中, 所述有机溶剂选自丙酮、 二氯曱烷、 乙醚、 氯仿、 乙酸乙 酯、 乙酸异 Wherein the organic solvent is selected from the group consisting of acetone, dichlorodecane, diethyl ether, chloroform, ethyl acetate, and acetic acid
丙酯、 曱苯、 正己烷、 乙腈中的一种或一种以上的混合溶剂。 这些有 机溶剂均为 1,3-二环己基脲(DCU )的不良溶剂和产物氰乙酸 -1-二苯 曱基 -3-氮杂环丁酯的良溶剂,所述良溶剂是在 0°C时溶质的溶解度大 于 30g/100mL, 不良溶剂是在 0°C时溶质的溶解度小于 lg/100mL。 One or a mixture of one or more of propyl ester, toluene, n-hexane, and acetonitrile. These organic solvents are good solvents for 1,3-dicyclohexylurea (DCU) and a good solvent for the product cyanoacetate-1-diphenylindol-3-azetidine, which is at 0°. The solubility of the solute at C is greater than 30 g/100 mL, and the poor solvent is such that the solubility of the solute is less than lg/100 mL at 0 °C.
优选的有机溶剂选自二氯曱烷、 氯仿、 乙醚、 乙酸乙酯、 曱苯、 乙腈中的一种或一种以上的混合溶剂。 A preferred organic solvent is one selected from the group consisting of dichlorosilane, chloroform, diethyl ether, ethyl acetate, toluene, acetonitrile or a mixed solvent of one or more.
所述碱水为饱和碳酸氢钠溶液。 The alkaline water is a saturated sodium bicarbonate solution.
2 ) Pinner反应: 将中间体(3 )、 无水乙醇加入到二氯曱烷中, 搅 拌并冷却 2) Pinner reaction: Add intermediate (3), absolute ethanol to dichlorosilane, stir and cool
至 -20~25°C ,通入干燥的氯化氢气体 0.5~10h,然后反应液在 -20 25 °C 继续密封搅拌 l~48h, 蒸除溶剂, 得 3-亚氨基 -3-乙氧基丙酸 -1- (二苯 曱基) -3-氮杂环丁酯盐酸盐 (4 )。 To -20~25 °C, dry hydrogen chloride gas is passed for 0.5~10h, then the reaction solution is kept sealed at -20 25 °C for 1~48h, and the solvent is distilled off to obtain 3-imino-3-ethoxypropane. Acid-1-(diphenylindenyl)-3-azetidinium hydrochloride (4).
3 ) 中和反应: 将中间体(4 )溶于二氯曱烷中, 控制 -5~25°C加入 碱,搅拌 l-5h,抽滤,滤液蒸除溶剂,得 3-亚氨基 -3-乙氧基丙酸 -1- (二 苯曱基 )-3-氮杂环丁酯(5 )。 3) Neutralization reaction: The intermediate (4) is dissolved in dichloromethane, and the base is added at -5 to 25 ° C, stirred for 1.5 to 5 hours, suction filtered, and the solvent is distilled off to obtain 3-imino-3. - ethoxypropionic acid-1-(diphenylhydrazinyl)-3-azetidinyl ester (5).
其中, 所述的碱选自有机碱和无机碱中的一种。 Wherein the base is selected from one of an organic base and an inorganic base.
其中, R R2、 R3分别独立的选自氢、 d-C4烷基、 苯基, 苯基
d-C4烷基, 条件为 R1 R2、 R3不同时为氢。 Wherein RR 2 and R 3 are independently selected from the group consisting of hydrogen, dC 4 alkyl, phenyl, phenyl dC 4 alkyl, with the proviso that R 1 R 2 and R 3 are not hydrogen at the same time.
优选的有机碱选自曱胺、 乙胺、 丙胺、二曱胺、二乙胺、 曱乙胺、 三乙胺、 苯胺、 N-曱基苯胺、 二异丙基乙胺、 Ν,Ν-二曱基苯胺、 乙二 胺。 Preferred organic bases are selected from the group consisting of decylamine, ethylamine, propylamine, decylamine, diethylamine, decylamine, triethylamine, aniline, N-mercaptoaniline, diisopropylethylamine, hydrazine, hydrazine-di Mercaptoaniline, ethylenediamine.
更优选的有机碱选自二曱胺、 二乙胺、 三乙胺、 苯胺、 乙二胺。 有机碱指 CrC4伯胺、 芳伯胺、 对称或不对称的 CrC4仲胺、 对 称或不对称的芳伯胺、 对称或不对称的 CrC4叔胺、 对称或不对称的 芳叔胺、 脂肪族二胺。 More preferred organic bases are selected from the group consisting of diamine, diethylamine, triethylamine, aniline, ethylenediamine. It refers to an organic base C r C 4 primary amines, aromatic primary amines, symmetric or asymmetric C r C 4 secondary amine, symmetrical or asymmetrical aromatic primary amine, symmetrical or asymmetrical tertiary C r C 4, symmetric or asymmetric Aromatic tertiary amine, aliphatic diamine.
所述无机碱选自碳酸钠、 碳酸钾、 碳酸氢钠、 碳酸氢钾、 氢氧化 钠和氢氧化钾。 The inorganic base is selected from the group consisting of sodium carbonate, potassium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate, sodium hydroxide and potassium hydroxide.
加入的碱使溶液的 pH为 7-10, 优选 7-8。 The base is added so that the pH of the solution is from 7 to 10, preferably from 7 to 8.
4 ) 成脒反应: 中间体 (5 ) 用乙腈溶解后加入醋酸铵, 升温至 40~60°C反应 4) Formation reaction: Intermediate (5) Dissolve in acetonitrile, add ammonium acetate, and heat up to 40~60 °C
0.5~10小时,冷却,抽滤,干燥得 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3- 氮杂环丁酯乙酸盐化合物 (6 )。 After 0.5 to 10 hours, it is cooled, suction filtered, and dried to give 3-amino-3-iminopropionic acid-1-(diphenylhydrazinyl)-3-azetidinium acetate compound (6).
本发明在中和反应中使用了有机碱, 减少了副反应, 提高了产品 纯度和收率。使用本发明方法制备阿折地平重要中间体 3-氨基 -3- 亚氨基丙酸 -1- (二苯曱 The present invention uses an organic base in the neutralization reaction, which reduces side reactions and improves product purity and yield. Preparation of an important intermediate of adipinepine using the method of the invention 3-amino-3-iminopropionic acid -1- (diphenylhydrazine)
基) -3-氮杂环丁酯乙酸盐, 能够简化操作过程、提高产品收率和纯度, 以中间体 3计三步反应总收率 73.1%, 产品纯度为 99.5%, 可直接用 于下一步的反应, 达到降低生产成本、 缩短反应周期的目的, 这在工 业化生产中很重要。
接下来, 通过以下具体实施例的描述, 对本发明的上述内容作进 一步的详细说明。对于本领域的技术人员而言, 不应将此理解为本发 明上述主题的范围仅限于以下的方法描述;凡基于本发明上述内容所 实现的技术均属于本发明的范围。 Benzyl azetidine acetate, which can simplify the operation process and improve product yield and purity. The total yield of the three-step reaction is 73.1% based on the intermediate 3, and the product purity is 99.5%. The next step is to reduce production costs and shorten the reaction cycle, which is important in industrial production. Next, the above content of the present invention will be further described in detail by the following description of specific embodiments. It should be understood by those skilled in the art that the scope of the above-mentioned subject matter of the present invention is limited to the following description of the method; the technology implemented based on the above-mentioned contents of the present invention is within the scope of the present invention.
实施例 Example
1、 氰乙酸 -1-二苯曱基 -3-氮杂环丁酯的制备(酯化) 1. Preparation of cyanoacetic acid-1-diphenylhydrazine-3-azetidine (esterification)
方法一: 将 1-二苯曱基 -3-吖丁啶醇 ( 2, 235g, 0.983mol )和氰 乙酸(1, 100g, 1.18mol )加入二氯曱烷 1.5L 中, 搅拌至全溶, 保 持 0-10°C下加入 Ν,Ν-二环己基碳二亚胺(DCC, 243g, 1.18mol ), 室温反应 3h。 反应毕, 将反应液冷却至 0-5 °C , 抽滤, 滤饼用少量二 氯曱烷冲洗, 滤液用饱和碳酸氢钠溶液洗涤, 再用水洗涤, 分离有机 层并用无水硫酸钠干燥, 减压蒸干有机溶剂, 干燥后得白色固体产品 275g, HPLC纯度 98.5%, 收率 93.7%。 Method 1: Add 1-diphenylhydrazin-3-azetidinol (2, 235 g, 0.983 mol) and cyanoacetic acid (1, 100 g, 1.18 mol) to 1.5 mL of dichloromethane, and stir until fully dissolved. Ν, Ν-dicyclohexylcarbodiimide (DCC, 243 g, 1.18 mol) was added at 0-10 ° C and allowed to react at room temperature for 3 h. After the completion of the reaction, the reaction mixture was cooled to 0 to 5 ° C, and filtered, filtered, washed with a small portion of dichloromethane. The organic solvent was evaporated to dryness under reduced pressure and dried to give 275 g of white solid.
方法二: 釆用氯仿作为反应溶剂, 操作同上, 于 55°C反应 5h, HPLC纯度 98.7%, 产物收率为 95.3%。 Method 2: chloroform was used as the reaction solvent, and the operation was the same as above, and the reaction was carried out at 55 ° C for 5 hours, the HPLC purity was 98.7%, and the product yield was 95.3%.
方法三: 釆用乙酸乙酯作为反应溶剂, 操作同上, 于 55°C反应 2h, HPLC纯度 98.9%, 产物收率为 96.1%。 Method 3: Ethyl acetate was used as the reaction solvent, and the operation was the same as above, and the reaction was carried out at 55 ° C for 2 h, the HPLC purity was 98.9%, and the product yield was 96.1%.
方法四: 釆用曱苯作为反应溶剂, 操作同上, 于 55°C反应 7h, HPLC纯度 98.5%, 产物收率为 94.7%。
2、 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸盐的 制备 ( Pinner反应 )
Method 4: Using hydrazine as the reaction solvent, the operation was the same as above, and the reaction was carried out at 55 ° C for 7 h, the HPLC purity was 98.5%, and the product yield was 94.7%. 2. Preparation of 3-imino-3-ethoxypropionic acid-1-(diphenylfluorenyl)-3-azetidinyl ester hydrochloride (Pinner reaction)
将中间体 3 ( 270g, 0.882mol )、 无水乙醇(61.8mL, 1.06mol ) 加入至 1.5L干燥的二氯曱烷中, 水盐浴中冷却至 -5~0°C , 通入干燥 的 HC1气体 2.5h, 通气完毕后, 保持反应液 0°C以下搅拌反应 6h。 Intermediate 3 (270 g, 0.882 mol), absolute ethanol (61.8 mL, 1.06 mol) was added to 1.5 L of dry dichloromethane, cooled to -5 to 0 ° C in a water salt bath, and dried. HC1 gas for 2.5 h, after the completion of the aeration, the reaction solution was kept under stirring at 0 ° C for 6 h.
0-4°C静置过夜。 反应毕, 减压蒸除溶剂, 得油状粘稠物中间体 4。 Allow to stand overnight at 0-4 °C. After completion of the reaction, the solvent was evaporated under reduced pressure to give an oily viscous intermediate 4 .
3、 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯的制备(中 3. Preparation of 3-imino-3-ethoxypropionic acid-1-(diphenylfluorenyl)-3-azetidinyl ester
方法一: 向中间体 4中加入 1.4L二氯曱烷, 冷却至 0-5°C , 向溶 液中滴加干燥的二乙胺 ( 182mL, 1.76mol ), 调节 pH7-8, 滴毕继续 搅拌 2h。 抽滤, 滤液减压蒸干溶剂, 得白色固体 5。 Method 1: Add 1.4 L of dichloromethane to Intermediate 4, cool to 0-5 ° C, add dry diethylamine (182 mL, 1.76 mol) to the solution, adjust pH 7-8, continue to stir after the dropwise addition. 2h. The mixture was suction filtered, and the filtrate was evaporated to dryness vacuo.
方法二: 选用二曱胺进行中和, 操作同上。 Method 2: Diamine is used for neutralization, and the operation is the same as above.
方法三: 选用三乙胺进行中和, 操作同上。 Method 3: Triethylamine is used for neutralization, and the operation is the same as above.
方法四: 选用乙二胺进行中和, 操作同上。 Method 4: Ethylenediamine is used for neutralization, and the operation is the same as above.
方法五: 向中间体 4中加入 1.4L二氯曱烷, 冷却至 0-5°C , 向溶 液中分批加入碳酸钾(242.88g, 1.76mol ), 调节 pH7-8, 加毕继续搅 拌 2h。 抽滤, 滤液减压蒸干溶剂, 得白色固体 5。
方法六: 选用碳酸钠进行中和, 操作同上。 Method 5: Add 1.4 L of dichloromethane to Intermediate 4, cool to 0-5 ° C, add potassium carbonate (242.88 g, 1.76 mol) to the solution in portions, adjust pH 7-8, continue stirring for 2 h. . The mixture was suction filtered, and the filtrate was evaporated to dryness vacuo. Method 6: Neutralize with sodium carbonate, and operate as above.
方法七: 选用氢氧化钠进行中和, 操作同上。 Method 7: Neutralize with sodium hydroxide, and operate as above.
4、 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙酸盐的制 备(成脒)
4. Preparation of 3-amino-3-iminopropionic acid-1-(diphenylindenyl)-3-azetidinyl acetate (formed into 脒)
向中间体 5 中加入 1.2L 乙腈, 溶解后加入醋酸铵 (68.0g, 0.882mol ), 升温至 55 °C反应 6h。 反应完毕自然冷却, 析晶, 抽滤, 乙腈洗滤饼, 干燥, 得白色固体 236g, 以中间体 3计三步反应总收 率为 69.9 73.1 %。
To the intermediate 5, 1.2 L of acetonitrile was added, and after dissolution, ammonium acetate (68.0 g, 0.882 mol) was added, and the mixture was heated to 55 ° C for 6 h. After the reaction, it was naturally cooled, crystallization, suction filtration, acetonitrile washing cake, and dried to give 236 g of a white solid. The total yield of the three-step reaction was 69.9 73.1%.
Claims
1、 一种 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙酸盐 的制备方法, 其特征在于, 包括以下步骤: 1. A method for preparing 3-amino-3-iminopropionic acid-1-(diphenylmethyl)-3-azetidinyl acetate, which is characterized in that it includes the following steps:
1 ) 酯化反应: 1-二苯曱基 -3-吖丁啶醇 (2)、 氰乙酸(1 ) 和 N,N- 二环己基碳二亚胺(DCC)在有机溶剂中于 0~80°C反应, 得氰乙酸 —7—二苯曱基 -3-氮杂环丁酯(3); 1) Esterification reaction: 1-diphenylmethyl-3-azetidinol (2), cyanoacetic acid (1) and N, N-dicyclohexylcarbodiimide (DCC) in an organic solvent at 0~ React at 80°C to obtain cyanoacetic acid-7-diphenylmethyl-3-azetidine ester (3);
2) Pinner反应: 将中间体(3)、 无水乙醇加入到二氯曱烷中, 搅 拌并冷却 2) Pinner reaction: Add intermediate (3) and absolute ethanol to dichloromethane, stir and cool.
至 -20~25°C, 通入干燥的氯化氢气体, 然后反应液在 -20~25°C继续密 封搅拌, 得 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸 盐 (4); to -20~25°C, pass dry hydrogen chloride gas, and then continue to seal and stir the reaction solution at -20~25°C to obtain 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl) ) -3-Azetidinyl hydrochloride (4);
3) 中和反应: 将中间体(4)溶于二氯曱烷中, 控制 -5~25°C加入 碱, 得 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯(5); 3) Neutralization reaction: Dissolve intermediate (4) in dichloromethane, add alkali at -5~25°C to obtain 3-imino-3-ethoxypropionic acid-1-(diphenylmethane) base) -3-azetidinyl ester (5);
4) 成脒反应: 中间体 (5 ) 用乙腈溶解后加入醋酸铵, 升温至 40~60°C反应, 得 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙 酸盐化合物 (6)。 4) Reaction to form amidine: Intermediate (5) is dissolved in acetonitrile, ammonium acetate is added, and the temperature is raised to 40~60°C for reaction to obtain 3-amino-3-iminopropionic acid-1-(diphenylmethyl)-3 -Azetidine acetate compound (6).
2、 一种 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3-氮杂环丁酯乙酸盐 的制备方法, 其特征在于, 包括以下步骤: 2. A method for preparing 3-amino-3-iminopropionic acid-1-(diphenylmethyl)-3-azetidinyl acetate, which is characterized in that it includes the following steps:
1 ) 酯化反应: 1-二苯曱基 -3-吖丁啶醇 (2)、 氰乙酸(1 ) 和 N,N- 二环己基碳二亚胺(DCC )在有机溶剂中于 0~80°C反应 0.5-11小时, 反应完毕冷却, 抽滤, 滤液碱水洗、 水洗, 干燥后蒸干溶剂, 得氰乙
酸 -1-二苯曱基 -3-氮杂环丁酯 ( 3 ); 1) Esterification reaction: 1-diphenylmethyl-3-azetidinol (2), cyanoacetic acid (1) and N, N-dicyclohexylcarbodiimide (DCC) in an organic solvent at 0~ React at 80°C for 0.5-11 hours. After the reaction is completed, cool down, filter with suction, wash the filtrate with alkaline water, wash with water, dry and evaporate the solvent to obtain ethyl cyanide. Acid-1-diphenylmethyl-3-azetidine (3);
2 ) Pinner反应: 将中间体(3 )、 无水乙醇加入到二氯曱烷中, 搅 拌并冷却 2) Pinner reaction: Add intermediate (3) and absolute ethanol to dichloromethane, stir and cool.
至 -20~25°C ,通入干燥的氯化氢气体 0.5~10h,然后反应液在 -20 25 °C 继续密封搅拌 l~48h, 蒸除溶剂, 得 3-亚氨基 -3-乙氧基丙酸 -1- (二苯 曱基) -3-氮杂环丁酯盐酸盐 (4 ); to -20~25°C, pass dry hydrogen chloride gas for 0.5~10h, and then continue to seal and stir the reaction solution at -20~25°C for 1~48h, evaporate the solvent to obtain 3-imino-3-ethoxypropane Acid-1-(diphenylmethyl)-3-azetidine hydrochloride (4);
3 ) 中和反应: 将中间体(4 )溶于二氯曱烷中, 控制 -5~25°C加入 碱,搅拌 l~5h,抽滤,滤液蒸除溶剂,得 3-亚氨基 -3-乙氧基丙酸 -1- (二 苯曱基 )-3-氮杂环丁酯(5 ); 3) Neutralization reaction: Dissolve intermediate (4) in dichloromethane, add alkali at -5~25°C, stir for 1~5h, filter with suction, and evaporate the solvent from the filtrate to obtain 3-imino-3 -Ethoxypropionic acid-1-(diphenylmethyl)-3-azetidine ester (5);
4 ) 成脒反应: 中间体 (5 ) 用乙腈溶解后加入醋酸铵, 升温至 40~60°C反应 4) Reaction to form amidine: Intermediate (5) is dissolved in acetonitrile, ammonium acetate is added, and the temperature is raised to 40~60°C for reaction.
0.5~10小时,冷却,抽滤,干燥得 3-氨基 -3-亚氨基丙酸 -1- (二苯曱基) -3- 氮杂环丁酯乙酸盐化合物 (6 )。 0.5~10 hours, cool, filter and dry to obtain 3-amino-3-iminopropionic acid-1-(diphenylmethyl)-3-azetidinyl acetate acetate compound (6).
3、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在酯化 反应中, 所述有机溶剂选自丙酮、二氯曱烷、 乙醚、 氯仿、 乙酸乙酯、 乙酸异丙酯、 曱苯、 正己烷、 乙腈中的一种或一种以上的混合溶剂。 3. The preparation method according to claim 1, characterized in that: in the esterification reaction, the organic solvent is selected from the group consisting of acetone, dichloromethane, diethyl ether, chloroform, ethyl acetate, isopropyl acetate, One or more mixed solvents from toluene, n-hexane, and acetonitrile.
4、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在酯 化反应中, 所述有机溶剂选自二氯曱烷、 氯仿、 乙醚、 乙酸乙酯、 曱 苯、 乙腈中的一种或一种以上的混合溶剂。 4. The preparation method according to claim 1, characterized in that: in the esterification reaction, the organic solvent is selected from dichloromethane, chloroform, diethyl ether, ethyl acetate, toluene, and acetonitrile. one or more mixed solvents.
5、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中 和反应中所述碱选自有机碱和无机碱中的一种; 5. The preparation method according to claim 1, characterized in that: in the neutralization reaction, the base is selected from one of organic bases and inorganic bases;
6、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中
和反应中所述有机碱为 NR^I^R3; 6. The preparation method according to claim 1, characterized in that: wherein, in The organic base described in the reaction is NR^I^R 3 ;
其中, in,
R R2、 R3分别独立的选自氢、 d-C4烷基、 苯基, 苯基 Ci-C4 烷基, 条件为 R1 R2、 R3不同时为氢。 RR 2 and R 3 are independently selected from hydrogen, dC 4 alkyl, phenyl, phenyl Ci-C 4 alkyl, provided that R 1 R 2 and R 3 are not hydrogen at the same time.
7、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中 和反应中所述有机碱选自曱胺、 乙胺、 丙胺、 二曱胺、 二乙胺、 曱乙 胺、 三乙胺、 苯胺、 N-曱基苯胺、 二异丙基乙胺、 Ν,Ν-二曱基苯胺、 乙二胺。 7. The preparation method according to claim 1, characterized in that: wherein the organic base in the neutralization reaction is selected from the group consisting of methylamine, ethylamine, propylamine, dimethylamine, diethylamine, methylethylamine, and triethylamine. Ethylamine, aniline, N-methylaniline, diisopropylethylamine, N,N-dimethylaniline, ethylenediamine.
8、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中 和反应中所述有机碱选自二曱胺、 二乙胺、 三乙胺、 苯胺、 乙二胺。 8. The preparation method according to claim 1, characterized in that: in the neutralization reaction, the organic base is selected from the group consisting of dimethylamine, diethylamine, triethylamine, aniline, and ethylenediamine.
9、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中 和反应中所述无机碱选自碳酸钠、 碳酸钾、 碳酸氢钠、 碳酸氢钾、 氢 氧化钠、 氢氧化钾。 9. The preparation method according to claim 1, wherein: in the neutralization reaction, the inorganic base is selected from the group consisting of sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, and potassium hydroxide. .
10、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中 和反应中加入的碱使溶液的 ρΗ为 7-10。 10. The preparation method according to claim 1, characterized in that: the alkali added in the neutralization reaction causes the pH of the solution to be 7-10.
11、 根据权利要求 1所述的制备方法, 其特征在于: 其中, 在中 和反应中加入的碱使溶液的 ρΗ为 7-8。 11. The preparation method according to claim 1, characterized in that: the alkali added in the neutralization reaction causes the pH of the solution to be 7-8.
12、 根据权利要求 1所述的制备方法, 其特征在于: 包括如下步 骤: 12. The preparation method according to claim 1, characterized in that: comprising the following steps:
将 0.983mol 1-二苯曱基 -3-吖丁啶醇和 1.18mol氰乙酸加入二氯 曱烷 1.5L中, 保持 0-10°C下加入 1.18mol Ν,Ν-二环己基碳二亚胺反 应, 反应毕, 将反应液冷却至 0-5°C , 抽滤, 滤饼用少量二氯曱烷冲
洗, 滤液用饱和碳酸氢钠溶液洗涤, 再用水洗涤, 分离有机层并用无 水硫酸钠干燥, 减压蒸干有机溶剂, 干燥后得白色固体氰乙酸 -1-二 苯曱基 -3-氮杂环丁酯; Add 0.983mol 1-diphenylmethyl-3-azetidinol and 1.18mol cyanoacetic acid to 1.5L of dichloromethane, and add 1.18mol N,N-dicyclohexylcarbodiimide while maintaining 0-10°C. Reaction, after the reaction is completed, cool the reaction solution to 0-5°C, filter with suction, and rinse the filter cake with a small amount of dichloromethane. Wash, the filtrate is washed with saturated sodium bicarbonate solution, and then washed with water. The organic layer is separated and dried with anhydrous sodium sulfate. The organic solvent is evaporated to dryness under reduced pressure. After drying, a white solid cyanoacetic acid-1-diphenylmethyl-3-nitrogen is obtained. heterocyclobutyl ester;
将 0.882mol氰乙酸 -1-二苯曱基 -3-氮杂环丁酯, 1.06mol无水乙 醇加入至 1.5L干燥的二氯曱烷中, 水盐浴中冷却至 -5~0°C , 通入干 燥的 HC1气体, 通气完毕后, 保持反应液 0°C以下搅拌反应, 得油状 粘稠物 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸盐, 向 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸盐中 加入 1.4L二氯曱烷, 冷却至 0-5°C , 向溶液中滴加干燥的 1.76mol二 乙胺, 调节 pH7-8, 滴毕继续搅拌, 得白色固体 3-亚氨基 -3-乙氧基丙 酸 -1- (二苯曱基) -3-氮杂环丁酯, Add 0.882 mol of 1-diphenylmethyl-3-azetidine cyanoacetate and 1.06 mol of absolute ethanol to 1.5 L of dry dichloromethane, and cool to -5~0°C in a water-salt bath. , add dry HC1 gas. After the ventilation is completed, keep the reaction solution below 0°C and stir the reaction to obtain an oily viscous substance 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3 -Azetidinyl hydrochloride, add 1.4L dichloromethane to 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3-azetidinyl hydrochloride alkane, cool to 0-5°C, add dry 1.76 mol diethylamine dropwise to the solution, adjust the pH to 7-8, and continue stirring after the dropwise addition, to obtain a white solid 3-imino-3-ethoxypropionic acid-1 - (Diphenylmethyl)-3-azetidine ester,
向 3-亚氨基 -3-乙氧基丙酸 -1 - (二苯曱基) -3-氮杂环丁酯中加入 1.2L乙腈, 加入 0.882mol醋酸铵, 升温至 55°C反应, 反应完毕, 得 白色固体。 Add 1.2L acetonitrile to 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3-azetidine, add 0.882mol ammonium acetate, heat to 55°C to react, react After completion, a white solid was obtained.
13、 根据权利要求 1所述的制备方法, 其特征在于: 包括如下步 骤: 13. The preparation method according to claim 1, characterized in that: comprising the following steps:
将 0.983mol 1-二苯曱基 -3-吖丁啶醇和 1.18mol氰乙酸加入二氯 曱烷 1.5L中, 搅拌至全溶, 保持 0-10°C下加入 1.18mol Ν,Ν-二环己 基碳二亚胺, 室温反应 3h, 反应毕, 将反应液冷却至 0-5°C , 抽滤, 滤饼用少量二氯曱烷冲洗, 滤液用饱和碳酸氢钠溶液洗涤, 再用水洗 涤, 分离有机层并用无水硫酸钠干燥, 减压蒸干有机溶剂, 干燥后得 白色固体氰乙酸 -1-二苯曱基 -3-氮杂环丁酯;
将 0.882mol氰乙酸 -1-二苯曱基 -3-氮杂环丁酯, 1.06mol无水乙 醇加入至 1.5L干燥的二氯曱烷中, 水盐浴中冷却至 -5~0°C , 通入干 燥的 HC1气体 2.5h, 通气完毕后, 保持反应液 0°C以下搅拌反应 6h, 0-4 °C静置过夜, 反应毕, 减压蒸除溶剂, 得油状粘稠物 3-亚氨基 -3- 乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸盐, Add 0.983 mol 1-diphenylmethyl-3-azetidinol and 1.18 mol cyanoacetic acid to 1.5 L of dichloromethane, stir until fully dissolved, and add 1.18 mol N, N-bicyclo while maintaining 0-10°C. Hexylcarbodiimide, react at room temperature for 3 hours. After the reaction is completed, cool the reaction solution to 0-5°C, filter with suction, rinse the filter cake with a small amount of dichloromethane, wash the filtrate with saturated sodium bicarbonate solution, and then wash with water. The organic layer was separated and dried over anhydrous sodium sulfate, and the organic solvent was evaporated to dryness under reduced pressure. After drying, white solid 1-diphenylmethyl-3-azetidinyl cyanoacetate was obtained; Add 0.882 mol of 1-diphenylmethyl-3-azetidine cyanoacetate and 1.06 mol of absolute ethanol to 1.5 L of dry dichloromethane, and cool to -5~0°C in a water-salt bath. , vent dry HC1 gas for 2.5h. After the aeration is complete, keep the reaction solution below 0°C and stir for 6h. Let it stand at 0-4°C overnight. After the reaction is completed, the solvent is evaporated under reduced pressure to obtain an oily viscous substance 3- Imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3-azetidine hydrochloride,
向 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯盐酸盐中 加入 1.4L二氯曱烷, 冷却至 0-5°C , 向溶液中滴加干燥的 1.76mol二 乙胺, 调节 pH7-8, 滴毕继续搅拌 2h。 抽滤, 滤液减压蒸干溶剂, 得 白色固体 3-亚氨基 -3-乙氧基丙酸 -1- (二苯曱基) -3-氮杂环丁酯, Add 1.4L dichloromethane to 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3-azetidine hydrochloride and cool to 0-5°C. Add 1.76 mol of dry diethylamine dropwise to the solution, adjust the pH to 7-8, and continue stirring for 2 hours after the dropwise addition. Suction filtration, the filtrate was evaporated to dryness under reduced pressure to obtain white solid 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3-azetidine ester.
向 3-亚氨基 -3-乙氧基丙酸 -1 - (二苯曱基) -3-氮杂环丁酯中加入 1.2L乙腈, 溶解后加入 0.882mol醋酸铵, 升温至 55°C反应 6h, 反应 完毕自然冷却, 析晶, 抽滤, 乙腈洗滤饼, 干燥, 得白色固体。
Add 1.2L acetonitrile to 3-imino-3-ethoxypropionic acid-1-(diphenylmethyl)-3-azetidine. After dissolving, add 0.882mol ammonium acetate and heat to 55°C for reaction. After 6 hours, the reaction was completed, cooled naturally, crystallized, filtered with suction, washed the filter cake with acetonitrile, and dried to obtain a white solid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310081090.7 | 2013-03-14 | ||
CN201310081090.7A CN103130700B (en) | 2013-03-14 | 2013-03-14 | Preparation method of azelnidipine intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014139410A1 true WO2014139410A1 (en) | 2014-09-18 |
Family
ID=48491205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/073222 WO2014139410A1 (en) | 2013-03-14 | 2014-03-11 | Method for preparing intermediate of azelnidipine |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103130700B (en) |
WO (1) | WO2014139410A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103130700B (en) * | 2013-03-14 | 2015-04-29 | 沈阳中海药业有限公司 | Preparation method of azelnidipine intermediate |
CN104860855B (en) * | 2014-12-08 | 2017-06-16 | 宁夏紫光天化蛋氨酸有限责任公司 | A kind of preparation method of the methylmercapto butyric acid ester of 2 hydroxyl of the D of high-purity, L 4 |
CN105949102A (en) * | 2016-06-20 | 2016-09-21 | 许昌豪丰化学科技有限公司 | Production method of azelnidipine intermediate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102453023A (en) * | 2010-10-21 | 2012-05-16 | 大丰市天生药业有限公司 | Process for producing azelnidipine |
CN103130700A (en) * | 2013-03-14 | 2013-06-05 | 沈阳中海药业有限公司 | Preparation method of azelnidipine intermediate |
CN103509003A (en) * | 2012-06-27 | 2014-01-15 | 威海威太医药技术开发有限公司 | Preparation method of azelnidipine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3491506B2 (en) * | 1997-10-14 | 2004-01-26 | 宇部興産株式会社 | Method for producing dihydropyridine derivative |
CN101475521B (en) * | 2008-11-13 | 2010-11-10 | 青岛黄海制药有限责任公司 | Method for synthesizing acetate of 1-benzhydryl-3-azetidine amidino acetic ester |
-
2013
- 2013-03-14 CN CN201310081090.7A patent/CN103130700B/en active Active
-
2014
- 2014-03-11 WO PCT/CN2014/073222 patent/WO2014139410A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102453023A (en) * | 2010-10-21 | 2012-05-16 | 大丰市天生药业有限公司 | Process for producing azelnidipine |
CN103509003A (en) * | 2012-06-27 | 2014-01-15 | 威海威太医药技术开发有限公司 | Preparation method of azelnidipine |
CN103130700A (en) * | 2013-03-14 | 2013-06-05 | 沈阳中海药业有限公司 | Preparation method of azelnidipine intermediate |
Non-Patent Citations (2)
Title |
---|
LIU, JIAN-FENG ET AL.: "Improved Synthesis of Azelnidipine", CHINESE JOURNAL OF MEDICINAL CHEMISTRY, vol. 20, no. 3, 30 June 2010 (2010-06-30), pages 192 - 194 * |
ZHANG, KAI ET AL.: "Synthesis of Azelnidipine", CHINESE JOURNAL OF PHARMACEUTICALS, vol. 39, no. 3, 31 March 2008 (2008-03-31), pages 163 - 165 * |
Also Published As
Publication number | Publication date |
---|---|
CN103130700B (en) | 2015-04-29 |
CN103130700A (en) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080031939A1 (en) | Process for the preparation of armodafinil | |
WO2012093402A1 (en) | Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide | |
CN107365275B (en) | High purity celecoxib | |
JP5503546B2 (en) | Separation of 4,5-dimethoxy-1- (methylaminomethyl) -benzocyclobutane | |
EA018227B1 (en) | A method for the preparation of dabigatran and its intermediates | |
WO2011160594A1 (en) | New preparation method of lapatinib | |
CN110590635A (en) | Preparation method of levetiracetam and intermediate thereof | |
WO2008138228A1 (en) | A process for the preparation of cilastatin sodium | |
WO2014139410A1 (en) | Method for preparing intermediate of azelnidipine | |
CN100591649C (en) | Method of preparing R-(+)-3-chlorophenylpropanol | |
KR102236806B1 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
EP3081554B1 (en) | Method for preparing silodosin and intermediate thereof | |
JP2018528233A (en) | Process for producing indoline compounds and novel indoline salts | |
WO2007094007A1 (en) | An improved process for the preparation of entacapone | |
WO2019239202A1 (en) | Novel & improved synthesis of antipsychotic drug | |
WO2011091677A1 (en) | Preparation method of aliskiren intermediate 3-amino-2,2-dimethyl propanamide | |
JP2010535185A (en) | Method for producing alfuzosin hydrochloride | |
CN103113408A (en) | Novel method for preparing fosfomycin phenylethylamine | |
CN112272665A (en) | Process for preparing sitagliptin | |
SK13592001A3 (en) | Synthesis of 3-amino-3-aryl propanoates | |
WO2012051737A1 (en) | Preparation method of cinacalcet and pharmaceutical salts thereof | |
JP2017516790A (en) | Method for producing AZD5363 and novel intermediate used therefor | |
WO2002064623A1 (en) | Process for preparation of peptide derivatives | |
KR20050062944A (en) | New process for preparing diisopropyl ((1-((2-amino-6-chloro-9h-purin-9-yl)methyl)cyclopropyl)oxy)-methylphosphonate | |
JP2007230906A (en) | Method for preparing n, n-dimethylcarbamoylmethyl 4-hydroxyphenylacetate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14763201 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 15-01-2016) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14763201 Country of ref document: EP Kind code of ref document: A1 |